Professor Albert E. G. Kreutzwendedich von dem Borne
Reduction of the diagnostic window in three cases of human immunodeficiency-1 subtype E primary infection with fourth-generation HIV screening assays
Batches of intravenous immunoglobulin associated with adverse reactions in recipients contain atypically high anti-Rh D activity
Restoration of red blood cell volume following 2-unit red blood cell apheresis
Cost-effectiveness of solvent/detergent-treated fresh-frozen plasma
Monitoring blood transfusion in patients undergoing coronary artery bypass grafting: an audit methodology
A Dc- phenotype encoded by an RHCE–D(5–7/8)–CE hybrid allele
Flow cytometry characterization of white cell-reduced blood: apoptosis markers and morphology of postfiltration elements
High proficiency in detecting the six major hepatitis C virus genotypes of laboratories involved in testing plasma by nucleic acid amplification technology
Post-transfusion purpura following liver transplantation
Seroprevalence of hepatitis C and B virus in multiply transfused β-thalassemics: results from a thalassemic day care unit in north India
Haemovigilance is associated with decreased use and improved appropriateness of blood transfusion
von Willebrand factor-cleaving protease content of Cohn plasma fractions
Estimate of transfusion-related acute lung injury incidence is not supported by UK data
Granulocyte–colony-stimulating factor-stimulated healthy donors and leukaemia risk
Future counselling of donors and recipients of blood products concerning prion-related diseases
Future counselling of donors and recipients of blood products concerning prion-related diseases
Future counselling of donors and recipients of blood products concerning prion-related diseases
Future counselling of donors and recipients of blood products concerning prion-related diseases
Future counselling of donors and recipients of blood products concerning prion-related diseases
Future counselling of donors and recipients of blood products concerning prion-related diseases
Future counselling of donors and recipients of blood products concerning prion-related diseases
Future counselling of donors and recipients of blood products concerning prion-related diseases
Future counselling of donors and recipients of blood products concerning prion-related diseases
Future counselling of donors and recipients of blood products concerning prion-related diseases
Future counselling of donors and recipients of blood products concerning prion-related diseases
Future counselling of donors and recipients of blood products concerning prion-related diseases
Future counselling of donors and recipients of blood products concerning prion-related diseases
Future counselling of donors and recipients of blood products concerning prion-related diseases
Future counselling of donors and recipients of blood products concerning prion-related diseases
Future counselling of donors and recipients of blood products concerning prion-related diseases
Future counselling of donors and recipients of blood products concerning prion-related diseases
Future counselling of donors and recipients of blood products concerning prion-related diseases
Report on the Eleventh International Society of Blood Transfusion Platelet Genotyping and Serology Workshop
The future use of pathogen-inactivated platelet concentrates
Diary of Events